Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K12 Inc LRN Dec 1, 2020 23.29 -0.17   
 Kadant, Inc. KAI Dec 1, 2020 128.80 +0.70   
 Kadmon Holdings, Inc. KDMN Dec 1, 2020 4.15 -4.82   
 Kaiser Aluminum Corporation KALU Dec 1, 2020 87.57 +12.30   
 Kaixin Auto Holdings - Ordinary Share KXIN Dec 1, 2020 7.03 +8.32   
 Kala Pharmaceuticals, Inc. KALA Dec 1, 2020 7.48 +0.27   
 Kaleido Biosciences, Inc. KLDO Dec 1, 2020 7.91 +0.38   
 Kaleyra, Inc. KLR Dec 1, 2020 9.50 +5.32   
 KalVista Pharmaceuticals, Inc. KALV Dec 1, 2020 19.26 +2.94   
 Kamada Ltd. - Ordinary Shares KMDA Dec 1, 2020 6.74 -0.59   
 Kaman Corporation KAMN Dec 1, 2020 53.07 +1.49   
 Kandi Technologies Group, Inc. KNDI Dec 1, 2020 8.57 -12.19   
 Kansas City Southern KSU Dec 1, 2020 187.10 +0.50   
 Kansas City Southern 4% PRF PERPETUAL USD 25 KSU- Dec 1, 2020 30.29 -5.29   
 KAR Auction Services, Inc KAR Dec 1, 2020 18.64 +3.27   
 Karuna Therapeutics, Inc. KRTX Dec 1, 2020 98.37 -1.40   
 Karyopharm Therapeutics Inc. KPTI Dec 1, 2020 16.92 -0.41   
 Kaspien Holdings Inc. KSPN Dec 1, 2020 12.61 0.00   
 Kayne Anderson Energy Infrastructure Fund, Inc. KYN Dec 1, 2020 6.08 +3.23   
 Kayne Anderson NextGen Energy & Infrastructure, Inc. KMF Dec 1, 2020 5.38 +2.48   
 Kazia Therapeutics Limited - American Depositary Shares KZIA Dec 1, 2020 9.90 -0.90   
 KB Financial Group Inc KB Dec 1, 2020 42.04 +1.08   
 KB Home KBH Dec 1, 2020 34.46 -2.10   
 KBL Merger Corp. IV KBLM Dec 1, 2020 4.99 0.00   
 KBL Merger Corp. IV - Unit KBLMU Dec 1, 2020 8.38 0.00   
 KBR, Inc. KBR Dec 1, 2020 28.06 +1.04   
 KBS Fashion Group Limited KBSF Dec 1, 2020 2.70 +4.25   
 KBW Bank Powershares KBWB Dec 1, 2020 47.78 +2.33   
 KBW High Div Yield Financial Powershares KBWD Dec 1, 2020 16.00 +1.52   
 KBW Prem Yield Equity REIT Powershares KBWY Dec 1, 2020 20.54 +1.88   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now